All Research


Title Date Pages
Recent Ideas: Activist Proxy Deadlines, CEO Transitions 2015-01-13
Consumer Jan. 5 - Jan. 9 2015-01-12
Amerisource barks, EMC adds some spinners, Owens says goodbye to old friend [ABC, EMC, OC, SHPG, LORL] 2015-01-12
Jan. 5 - Jan. 9 2015-01-09
Setting the DuPont o/u at 1.5 seats, Raytheon puts cyber biz in senior hands, more than noise at Marvell? [DD, RTN, MRVL, MHFI, OAS] 2015-01-09
Key domino falls at MeadWest, Valeant remains very much in the game, Lilly is looking but not for elephants, [MWV, VRX, LLY, HP, DKS] 2015-01-08
IPG singing same song into proxy season, Thermo not thinking outside its box, Verizon with a changeup [IPG, TMO, VZ, HLF, MON, MTW] 2015-01-07
SLXP open to talk?, ValueAct blows off a little steam at MSCI, some not so subtle put buying at Nuance [SLXP, MSCI, NUAN] 2015-01-06
CEO Watch-List 2015-01-06
A proxy season preview, Equinix still waiting, an oasis for activism in the energy patch [IPG, MWV, YHOO, DD, ZTS, YUM, MCD, MTW, EQIX, OAS] 2015-01-05
Dec. 29 - Dec. 30 2015-01-05
Corvex braves the ARCP minefield, Computer Sciences cleans up an old mess, a couple of Elliott situations are ripening [ARCP, CSC, EMC, IPG, CVEO] 2014-12-30
Icahn resuscitates Manitowoc story, revisiting two medtech sale processes, short interest analysis [MTW, BCR, SYK, IPG, HRB, RIG, TLM] 2014-12-29
Consumer Dec. 15 - Dec. 19 2014-12-22
Dec. 15 - Dec. 19 2014-12-22
Madison Square Garden draws up new game plan, Stanley tosses in the towel, not quite ready to give up on Computer Sciences [MSG, SWK, CSC, CAG, HOT, IHG] 2014-12-19
Rite Aid story quickly turns, a Molotov cocktail thrown at Owens-Illinois, navigating through the Navistar selloff [RAD, OI, WIN, NAV, SD] 2014-12-18
Brookdale slides into the spotlight, CVS leaving ESRX behind, Salix seeks early parole [BKD, ESRX, CFX, PETM, SLXP] 2014-12-17
Stryker arranges some possible short-term financing, Express Scripts with a quick CFO hook, portfolio shaping at LLL [SYK, ESRX, LLL, IHG, WCG] 2014-12-16
Consumer Dec. 8 - Dec. 12 2014-12-15

Contact us here for help accessing content or arranging a relationship with our firm.